Edition:
India

Ptc Therapeutics Announces First Commercial Milestone Payment Following U.S. FDA Approval Of Evrysdi™


Wednesday, 26 Aug 2020 

Aug 26 (Reuters) - PTC Therapeutics Inc ::PTC THERAPEUTICS ANNOUNCES FIRST COMMERCIAL MILESTONE PAYMENT FOLLOWING U.S. FDA APPROVAL OF EVRYSDI™ (RISDIPLAM).PTC THERAPEUTICS - ACHIEVED A $20 MILLION MILESTONE PAYMENT FROM ROCHE UNDER ITS LICENSE AND COLLABORATION AGREEMENT. 

Company Quote

41.73
0.91 +2.23%
1 Dec 2020